184 related articles for article (PubMed ID: 2886896)
1. Relative effectiveness and costs of antiulcer medications as a basis for rational prescribing.
McLean AJ; Harcourt DM; McCarthy PG; Dudley FJ; McNeil JJ
Med J Aust; 1987 Apr; 146(8):431-3, 436-8, 442. PubMed ID: 2886896
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
3. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
Bianchi Porro G; Parente F
J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
[TBL] [Abstract][Full Text] [Related]
4. Drugs for treatment of peptic ulcers.
Dajani EZ; Trotman BW
J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
[TBL] [Abstract][Full Text] [Related]
5. Drug therapy for peptic ulcer: drugs that act on the gastric mucosa.
Kauffman GL
J Clin Gastroenterol; 1981; 3(Suppl 2):95-101. PubMed ID: 6119340
[TBL] [Abstract][Full Text] [Related]
6. Drug therapy of peptic ulcer disease.
Peppercorn MA
Compr Ther; 1983 Nov; 9(11):47-52. PubMed ID: 6139199
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approach to ulcer healing.
Blum AL
Am J Med; 1985 Aug; 79(2C):8-14. PubMed ID: 2863981
[TBL] [Abstract][Full Text] [Related]
8. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Wagstaff AJ; Benfield P; Monk JP
Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
[TBL] [Abstract][Full Text] [Related]
9. Drugs for the prevention of peptic ulcer recurrence.
Piper DW
Drugs; 1983 Nov; 26(5):439-53. PubMed ID: 6315333
[TBL] [Abstract][Full Text] [Related]
10. Anti-ulcer therapy. Past to present.
Bettarello A
Dig Dis Sci; 1985 Nov; 30(11 Suppl):36S-42S. PubMed ID: 2865091
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
Belousov IuB; Karpov OI; Belousov DIu; Beketov AS
Ter Arkh; 2007; 79(2):58-66. PubMed ID: 17460971
[No Abstract] [Full Text] [Related]
12. The other option in peptic ulcer therapy.
Halter F
S Afr Med J; 1984 Jun; 65(25):996-1000. PubMed ID: 6374932
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic options for the control of peptic ulcer disease.
Levine JB
Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
[No Abstract] [Full Text] [Related]
14. Pathogenesis and therapy of peptic ulcer disease.
Peterson WL
J Clin Gastroenterol; 1990; 12 Suppl 2():S1-6. PubMed ID: 1978840
[TBL] [Abstract][Full Text] [Related]
15. Current concepts in clinical therapeutics: peptic ulcer disease.
Siepler JK; Mahakian K; Trudeau WT
Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
[TBL] [Abstract][Full Text] [Related]
16. The medical management of peptic ulcer.
Shearman DJ; Hetzel D
Annu Rev Med; 1979; 30():61-79. PubMed ID: 45409
[No Abstract] [Full Text] [Related]
17. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
18. Clinical indications and efficacy of colloidal bismuth subcitrate.
Lambert JR
Scand J Gastroenterol Suppl; 1991; 185():13-21. PubMed ID: 1957121
[TBL] [Abstract][Full Text] [Related]
19. [Current trends in medical therapy of gastroduodenal ulcer].
Grassi M; Fraioli A; Messina B
Clin Ter; 1987 Dec; 123(6):475-86. PubMed ID: 2902954
[No Abstract] [Full Text] [Related]
20. Medical treatment of peptic ulcer disease.
Andersen BN
Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
